New Delhi, March 28:
HCL Infosystems is all set to launch its range of made-in-India tablet PCs, with prices starting from about Rs 15,000. A formal announcement is expected this week, a source familiar with the development said.
“The Android-based HCL ME Tablets will be available in 7-inch and 10-inch screen sizes and three price points” Rs 14,990, Rs 25,790, and Rs 32,990.
Source: Business Line, 28.03.2011
Also see: a report in the Economic Times
Delivering end-to-end Telecom solutions closer to customers
Bonn, 10th March, 2011: Tech Mahindra, India’s leading provider of solutions and services to the telecommunications industry and part of the US $ 8.25 Billion, Mahindra Group, announced the inauguration of its development centre in Bonn, Germany. The state-of-the art facility located in Sirius Business Park, encompasses fully-equipped infrastructure to service clients in Germany as well as Central Europe. Tech Mahindra, providing end-to-end telecom solutions to Telcos globally, has an annual turnover of US$ 976.6 Mn, of which, annual turnover of US$ 976.6 Mn, of which, the contribution of Europe is almost 54%. Within Europe, Germany is the largest revenue contributing country after UK, for Tech Mahindra. The company started its operations in Germany more than 10 years back with offices in Munich and Dusseldorf. Through this strategic move Tech Mahindra plans to further leverage its proven capabilities as a transformation partner and provide an array of business and technology, closer to the customer.
Speaking on the occasion, Mr. Rishi Bhatnagar, AVP-Tech Mahindra said, “As a global player and leader in the Telecommunications domain, we are always keen on strengthening our local front-end capabilities in the region. This development centre will intensify Tech Mahindra’s reach, traction and growth plans within Germany, and enable us to transfer value advantage to our customers. Currently, we have three large engagements in Germany, supporting our Telcos with end-to-end development, Managed Services, large scale legacy outsourcing and transformation among others services. For Tech Mahindra, Europe is a critical market with immense potential and growth.”
The company has a global footprint in 25 countries with 126 clients worldwide. This new facility, equipped with world class infrastructure, will focus on building up localized capabilities to serve Tech Mahindra’s European clientele.
About Tech Mahindra
Tech Mahindra is a leading provider of solutions and services to the telecommunications industry, part of the US$ 8.25 Billion Mahindra Group, India. With total revenues of US $ 976.6 million for FY0910, Tech Mahindra serves telecom service providers, telecom equipment manufacturers, and software vendors. Tech Mahindra enables clients to maximize return on IT investment by providing solutions which help the clients achieve shorter time-to-market, reduced total cost of ownership, and high customer satisfaction. Tech Mahindra achieves this through its domain and process expertise, distinctive IT skills, research and development, and proven innovative delivery models. Assessed at SEI-CMMi Level 5, Tech Mahindra is supported by over professionals from across the globe who provide a unique blend of culture, domain expertise and in-depth technology skill-sets.
For more details please contact:
Smriti Dave
Tel. +91 20 6601 8100, Extn.1779
Mobile: +91 9881124858
corporate.communications@techmahindra.com
Source: Company press release
CARIn (Center of Application & Research in India) focuses on research in the field of ophthalmology
JENA/Germany, 07.02.2011.
Carl Zeiss Meditec has opened its Center for Application and Research (CARIn) in India this weekend. With this move, Carl Zeiss Meditec is strengthening its presence in high growth markets like India and targeting its investments at research and development projects. Carl Zeiss has already been represented with its own sales and service company in the country’s large urban centers since 1997.
Dr. Michael Kaschke, President and CEO of Carl Zeiss AG and responsible for the Asia region on the Executive Board, since 1 January 2011, comments on the opening of CARIn as follows: “Carl Zeiss has been active in India for more than ten years. However, for our company the country is more than a sales market: our customer base, as well as the industrial and research landscapes, have a lot more to offer. Therefore, in India we are investing not only in the expansion of our sales and service network, but also in product and application development. In this process, we are working very closely with our customers and partners in science.”
“Innovations form the foundation of our strategy that makes the latest medical technology available to high growth markets like India,” says Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG. “In the past, we already succeeded in developing products tailored specifically to the needs of doctors in these countries. With our own Center of Application and Research in India and a team of highly motivated staff, we can work even more closely with customers on site and integrate their needs even more effectively into our product developments.”
Research and development activities of CARIn at a glance:
CARIn – Facts and figures
CARIn, the Center of Application & Research in India, is located in the immediate vicinity of the Carl Zeiss sales and service company in Bangalore. The research and development work will initially be focused on systems for use in ophthalmology. Over the long term, however, the R&D activities will be expanded to include the entire product spectrum of Carl Zeiss Meditec. The first employees for the new center have already been recruited. The capacity will be expanded to up to 50 staff in the mid term.
Image Download (JPG: 2.0 MB)
CARIn, the new Centre of Application and Research of Carl Zeiss Meditec in Bangalore, India
Eva Sesselmann
Group Communications
Carl Zeiss Meditec AG
Phone: +49 3641 220-331
Fax: +49 3641 220-112
E-Mail: 
press@meditec.zeiss.com
Patrick Kofler
Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220-106
Fax: +49 3641 220-117
E-Mail: investors@meditec.zeiss.com
Number: 0014-2011-ENG OP